Starfire Investment Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Starfire Investment Advisers’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.04M	Buy	7,634 +29	+0.4%	+$3.7K	0.5%	53
2020 Q1	$819K	Hold	7,605	–	–	0.45%	58
2019 Q4	$916K	Hold	7,605	–	–	0.35%	66
2019 Q3	$756K	Hold	7,605	–	–	0.31%	75
2019 Q2	$829K	Hold	7,605	–	–	0.37%	64
2019 Q1	$850K	Hold	7,605	–	–	0.39%	61
2018 Q4	$733K	Buy	7,605 +1,800	+31%	+$191K	0.4%	59
2018 Q3	$707K	Hold	5,805	–	–	0.35%	63
2018 Q2	$637K	Hold	5,805	–	–	0.32%	71
2018 Q1	$619K	Buy	+5,805	New	+$643K	0.32%	74
2017 Q4	–	Sell	-5,805	Closed	-$645K	–	179
2017 Q3	$645K	Hold	5,805	–	–	0.39%	56
2017 Q2	$600K	Hold	5,805	–	–	0.35%	65
2017 Q1	$559K	Hold	5,805	–	–	0.3%	74
2016 Q4	$514K	Sell	5,805 -300	-5%	-$27.3K	0.29%	74
2016 Q3	$589K	Sell	6,105 -2,145	-26%	-$204K	0.35%	64
2016 Q2	$708K	Sell	8,250 -525	-6%	-$47.1K	0.49%	46
2016 Q1	$763K	Hold	8,775	–	–	0.5%	44
2015 Q4	$990K	Buy	8,775 +1,875	+27%	+$204K	0.68%	41
2015 Q3	$698K	Hold	6,900	–	–	0.51%	47
2015 Q2	$849K	Hold	6,900	–	–	0.56%	45
2015 Q1	$790K	Buy	+6,900	New	+$761K	0.52%	47

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Starfire Investment Advisers's IBB Position: Q2 2020 in Review

Starfire Investment Advisers increased its iShares Biotechnology ETF (IBB) stake by 0.38% in Q2 2020, buying an estimated $3.7K and bringing the position to 7,634 shares worth $1.04M. The position accounts for 0.5% of the portfolio, ranked #53.

Starfire Investment Advisers first reported a position in IBB in Q1 2015 and has held it in 21 quarters since. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Starfire Investment Advisers held 7,634 shares of iShares Biotechnology ETF worth $1.04M as of Q2 2020.
Starfire Investment Advisers bought 29 iShares Biotechnology ETF shares in Q2 2020, an estimated $3.7K.
iShares Biotechnology ETF made up 0.5% of Starfire Investment Advisers's portfolio in Q2 2020, its #53 holding.
Starfire Investment Advisers first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 21 quarters since.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.